Zaczek R, Hurt S, Culp S, De Souza E B
Neurobiology Laboratory, National Institute on Drug Abuse, Baltimore, MD 21224.
NIDA Res Monogr. 1989;94:223-39.
Brain recognition sites have been identified for [3H]MDA and [3H]MDMA. The dissociation constants of MDA and MDMA for these sites are similar to the concentrations needed to affect several brain neurochemical parameters and are in keeping with concentrations of MDA in brain (165 microM) following administration of behaviorally active doses (20 mg/kg) of the drug. While the characteristics of these binding sites suggest a possible hydrophobic interaction with brain membranes, this interaction is not without specificity, since it has a unique pharmacology and a heterogeneous distribution in brain. Similarities have been found between [3H]MDA binding studied in the present report and that of apparent 3Hamphetamine binding studied by Hauger et al. (1984). Both have extremely high Bmax values, are optimal in p2 preparations, are stabilized by sucrose, and share similar patterns of regional distribution. Measuring the specific binding of [3H]amphetamine, [3H]fenfluramine, [3H]MDA, and related compounds under identical conditions will be required to determine the possible relationships among the interactions of these compounds with brain membranes. Further study is also needed to determine the possible importance such interactions of amphetamine and its substituted analogs may have with brain membranes in relation to the pharmacology of these substances.
已确定了[3H]MDA和[3H]MDMA在大脑中的识别位点。MDA和MDMA与这些位点的解离常数类似于影响多种大脑神经化学参数所需的浓度,并且与给予行为活性剂量(20mg/kg)药物后大脑中MDA的浓度(165μM)相符。虽然这些结合位点的特征表明其可能与脑膜存在疏水相互作用,但这种相互作用并非没有特异性,因为它具有独特的药理学特性和在大脑中的异质性分布。在本报告中研究的[3H]MDA结合与Hauger等人(1984年)研究的表观3H苯丙胺结合之间发现了相似之处。两者都具有极高的Bmax值,在p2制剂中最佳,由蔗糖稳定,并具有相似的区域分布模式。需要在相同条件下测量[3H]苯丙胺、[3H]芬氟拉明、[3H]MDA及相关化合物的特异性结合,以确定这些化合物与脑膜相互作用之间的可能关系。还需要进一步研究来确定苯丙胺及其取代类似物的这种相互作用与这些物质的药理学相关时,对脑膜可能具有的重要性。